Page last updated: 2024-10-23

azelastine and 2019 Novel Coronavirus Disease

azelastine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Klussmann, JP1
Grosheva, M1
Meiser, P1
Lehmann, C1
Nagy, E1
Szijártó, V1
Nagy, G1
Konrat, R1
Flegel, M1
Holzer, F1
Groß, D1
Steinmetz, C1
Scherer, B1
Gruell, H1
Schlotz, M1
Klein, F1
de Aragão, PA1
Morr, H1
Al Saleh, H1
Bilstein, A1
Russo, B1
Müller-Scholtz, S1
Acikel, C1
Sahin, H1
Werkhäuser, N1
Allekotte, S1
Mösges, R1

Trials

1 trial available for azelastine and 2019 Novel Coronavirus Disease

ArticleYear
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
    Scientific reports, 2023, 04-26, Volume: 13, Issue:1

    Topics: COVID-19; Double-Blind Method; Humans; Nasal Sprays; SARS-CoV-2; Treatment Outcome; Viral Load

2023